Cancer, Advanced Active Not Recruiting Phase 1 Trials for Nivolumab (DB09035)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Active Not Recruiting1 IdentifierTitlePurposeDrugs
NCT03203876A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid TumorsTreatment